Explore 3 Stock Ideas & Industry Insights Download Free Report
Assessing the Upcoming Dividend and Financial Health of Goodman Group (GMGSF) Goodman Group (GMGSF) recently announced a dividend of $0.15 per share, payable on 2024-02-23, with the ex-dividend date set for 2023-12-28. As investors look forward to this upcoming payment, the spotlight also shines …
Understanding the Upcoming Dividend Payout and Historical Performance Transurban Group(TRAUF) recently announced a dividend of $0.3 per share, payable on 2024-02-13, with the ex-dividend date set for 2023-12-28. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend …
Delving Into the Dividends of TC Energy Corp (NYSE:TRP) TC Energy Corp (NYSE:TRP) recently announced a dividend of $0.93 per share, payable on 2024-01-31, with the ex-dividend date set for 2023-12-28. As investors look forward to this upcoming payment, the spotlight also shines on …
A silicon wafer with chips etched into at a research facility, in Sunnyvale, California, US. (POOL New / reuters) Semiconductors and chips proved to be a hot talking point in 2023 for business, with the rise of artificial intelligence (AI) and what seemed to …
Grainger plc (LON:GRI) has announced that it will be increasing its dividend from last year's comparable payment on the 14th of February to £0.0437. Even though the dividend went up, the yield is still quite low at only 2.4%. See our latest analysis for …
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage to find investors. But the reality is that …
Key Insights Using the 2 Stage Free Cash Flow to Equity, Bapcor fair value estimate is AU$9.82 Current share price of AU$5.55 suggests Bapcor is potentially 43% undervalued The AU$6.96 analyst price target for BAP is 29% less than our estimate of fair value …
Key Insights The projected fair value for Neuren Pharmaceuticals is AU$43.02 based on 2 Stage Free Cash Flow to Equity Current share price of AU$24.04 suggests Neuren Pharmaceuticals is potentially 44% undervalued Analyst price target for NEU is AU$26.43 which is 39% below our …
Key Insights The projected fair value for Iluka Resources is AU$9.11 based on 2 Stage Free Cash Flow to Equity Iluka Resources is estimated to be 27% undervalued based on current share price of AU$6.68 Analyst price target for ILU is AU$8.28 which is …
While it may not be enough for some shareholders, we think it is good to see the Cogeco Inc. (TSE:CGO) share price up 20% in a single quarter. But that doesn't help the fact that the three year return is less impressive. Truth be …
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…